Navigation Links
TOPICA Begins Phase 2 Clinical Trial of Potent Antifungal, Luliconazole, in Athlete's Foot
Date:4/22/2009

PALO ALTO, Calif., April 22 /PRNewswire/ -- TOPICA Pharmaceuticals today announced the enrollment of patients in a Phase 2 clinical trial evaluating luliconazole for the treatment of tinea pedis (athlete's foot). Luliconazole, the company's lead product candidate, is the one of the most potent and broad spectrum molecules in the imidiazole class of antifungal agents, giving it the potential to provide physicians and patients with a needed topical solution to a variety of skin and nail fungal infections.

"The initiation of this trial represents a significant milestone for TOPICA as we begin our U.S. clinical development program of this promising drug candidate, which already has been proven in millions of patients in Japan," said Greg Vontz, president and chief executive officer of TOPICA. "We expect to complete this trial by the end of this year, potentially enabling us to initiate our pivotal Phase 3 clinical trial in 2010."

Phase 3 data from clinical studies conducted in Japan demonstrated that luliconazole successfully treated tinea pedis in half the time of commonly prescribed products. Since the 2005 approval of luliconazole in Japan for the treatment of tinea infections, more than 4 million patients have been safely treated with luliconazole. TOPICA has an exclusive license to develop and market luliconazole in the Americas and Europe.

The Phase 2, multi-center, randomized, double blind, trial is evaluating the safety and optimal duration of 1 percent luliconazole cream administered once daily for 14 or 28 days in patients with tinea pedis. The primary efficacy endpoint is to achieve complete clearance of the infection at two weeks post treatment. Currently in the U.S. available prescription medications generally require treatment once or twice a day for up to four weeks to achieve this result. The company expects to enroll approximately 120 patients in the trial, which is being conducted at 5 clin
'/>"/>

SOURCE TOPICA Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Summit VetPharm Offers New Flea Topical Vectra for Dogs & Puppies(TM) For Long-Lasting Protection
2. New Topical Painkiller Relieves Severe Pain in Minutes
3. Topical Dermatological Product Development in the USA Workshop to Be Held on June 4, 2009 in East Brunswick, New Jersey, USA
4. Chronic Pain Sufferers Report Relief: DRJ Group Teams With Adult Foster Care Facilities to Evaluate Effectiveness of Stopain Topical Analgesic
5. Topical Spray Helped Men With Premature Ejaculation
6. Perrigo Announces FDA Approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)
7. Global Warming Expected to Spike Pollen and Spring Allergies - New Drug-Free Topical Gels Boost Hope for Allergy Sufferers
8. Study Shows Nonprescription LCD Topical Solution is More Effective than Prescription-Strength Calcipotriol Cream for Moderate Plaque Psoriasis
9. The Texas Institute of Dermatology Team Finds Easy-to-Apply, Topical Drug Just as Good as Injectable Compound for a Disfigurating Skin Infection
10. NanoBio to Announce Key Clinical and Preclinical Data on Its Topical Anti-infective Lotions at AAD 2009
11. American Academy of Dermatology Issues New Guidelines For The Management of Psoriasis With Topical Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 04, 2015 , ... ... brings an automatic end to driving, says the August 2015 Harvard Health Letter. ... okay to drive. It requires an individual assessment of skills," says Lissa Kapust, ...
(Date:8/4/2015)... NY (PRWEB) , ... August 04, 2015 , ... ... mortgage lender specializing in healthcare finance, announced the closing of a $118 million ... two campus health system located in Smithfield and Clayton, North Carolina. JHSC ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... Process Chemistry and Scale-up Online Seminar featuring researchers from Lubrizol, Pfizer, and ... at 1:00 PM EDT. , Process development project timelines often require informed decisions ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... Updated enrollment ... (AIS) in-house research team, can now be accessed at http://www.AISHealth.com . The data ... Directory of Health Plans: 2015, the tables and charts on the website’s “Data” section ...
(Date:8/4/2015)... Ill. (PRWEB) , ... August 04, 2015 , ... ... and the specialty in which the physician is board-certified is increasingly influential in ... for Dermatologic Surgery. , The 2015 ASDS Consumer Survey on Cosmetic Dermatologic Procedures ...
Breaking Medicine News(10 mins):Health News:Assessment Can Help Older Drivers Keep Driving Safely, from the August 2015 Harvard Health Letter 2Health News:Armadale Capital Inc. Refinances $118 Million for Johnston Health Services Corporation 2Health News:Armadale Capital Inc. Refinances $118 Million for Johnston Health Services Corporation 3Health News:METTLER TOLEDO Announces New Process Chemistry and Scale-up Online Seminar 2Health News:Atlantic Information Services Website Offers Up-to-Date U.S. Health Plan Enrollment Data 2Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 2Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 3Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 4
... driving the trend, study says , , TUESDAY, Nov. 6 ... disease is on the rise, and diabetes and high blood ... the increase, a new study suggests. , "When we looked ... was more common than previously appreciated," said lead researcher Dr. ...
... ... http://www.amerathonclub.com Encourages Consistent Exercise for Individuals and ... Families -, PITTSBURGH, ... while maintaining a healthy,lifestyle. The Amerathon Club has introduced a new online and interactive,total ...
... Healthcare NHS Trust Implements Ericom,s Alternative to Citrix ... ... 6 ,Ericom(R) Software, a leading provider of Enterprise-Wide Application,Access solutions, ... selected PowerTerm(R) WebConnect Enterprise edition to provide,employees with secure access ...
... is available in Spanish . , ANN ARBOR, Mich. ... the fact that nearly one in five American women still smokes, ... possible reasons for the stubborn persistence of smoking, fear of weight ... University of Michigan Health System researcher who has devoted much of ...
... work together to maintain addiction, study suggests , , TUESDAY, ... know all too well, drinking and smoking tend to ... might be so. , It,s well known that, "The ... someone continues smoking," noted lead researcher Thomas J. Gould, ...
... for State,s Second Site, ATLANTA, Nov. 6 ... has named Atlanta Medical Center as Georgia,s second,hospital ... March,of Dimes NICU Family Support(R) provides information and ... newborns being cared for in,a Neonatal Intensive Care ...
Cached Medicine News:Health News:Kidney Disease Increasing in U.S. 2Health News:Kidney Disease Increasing in U.S. 3Health News:Innovative Amerathon Club Website 'Virtual' Journey to Good Health 2Health News:UK Government (NHS) Selects Ericom to Enable Secure Application Access for its Medical and Administrative Staff 2Health News:Is fear of gaining weight keeping many women from trying to quit smoking? 2Health News:Is fear of gaining weight keeping many women from trying to quit smoking? 3Health News:Is fear of gaining weight keeping many women from trying to quit smoking? 4Health News:Nicotine Plus Alcohol May Be Tough to Beat 2Health News:Nicotine Plus Alcohol May Be Tough to Beat 3Health News:Georgia Receives Second March of Dimes NICU Family Support(R) Project 2Health News:Georgia Receives Second March of Dimes NICU Family Support(R) Project 3
(Date:8/4/2015)... 2015  Syneron Medical Ltd. (NASDAQ: ELOS ), a ... the three month period ended June 30, 2015. ... Highlights: , Revenue of $73.5 million, ... North American product sales grew 45% year-over-year. , International ... 14% product growth in the EMEA region and 25% product ...
(Date:8/4/2015)... , Aug. 4, 2015  Ironshore Pharmaceuticals ... with Restore Health, a company specializing in personalized ... double-blind clinical trial, designed to evaluate the safety ... development to treat Attention-deficit/hyperactivity disorder (ADHD). This is ... Restore Health originally partnered with Ironshore in ...
(Date:8/3/2015)... Aug. 4, 2015   The Intellectual Property ... world,s leading provider of intelligent information for businesses ... 2015 CMR Pharmaceutical R&D Factbook , the biopharmaceutical ... concerns around declines in R&D, the analysis identifies ... trillion milestone and forecasts sales to reach $1.3 ...
Breaking Medicine Technology:Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 2Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 3Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 4Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 5Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 6Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 7Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 8Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 9Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 10Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 11Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 12Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 13Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 14Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 15Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 16Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 17Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2Pharma Sales to Grow Beyond $1 Trillion 2
... March 31, 2011 Reportlinker.com announces that a new ... Cardiac Marker Diagnostic Testing Markets ... purpose of this TriMark Publications report is to describe ... (IVD) market devoted to cardiac marker testing. This study ...
... Virtual Radiologic (vRad), a technology-enabled national radiology ... Sales & Customer Service. vRad® Results (SM) is a ... that provides secure access to images and radiology reports ... devices and the Internet. vRad received the award in ...
Cached Medicine Technology:Reportlinker Adds Cardiac Marker Diagnostic Testing Markets 2Reportlinker Adds Cardiac Marker Diagnostic Testing Markets 3Reportlinker Adds Cardiac Marker Diagnostic Testing Markets 4Reportlinker Adds Cardiac Marker Diagnostic Testing Markets 5Reportlinker Adds Cardiac Marker Diagnostic Testing Markets 6Reportlinker Adds Cardiac Marker Diagnostic Testing Markets 7Reportlinker Adds Cardiac Marker Diagnostic Testing Markets 8Virtual Radiologic Wins Stevie® Award for Improving Patient Care through Mobile Technology 2
VersaStep™ Reposable Sterilization Trays....
... device is comprised of the following components. ... port are also packaged in the following ... with 12 mm Step™ cannula assembly and ... mm locking cone with 10/12 mm Reposable ...
... components are supplied sterile. , ,The Step™ ... sterile in 2/3, 5, 7/8, 10 and 12 ... They are used in conjunction with the Step™ ... Expandable Sleeve. The 5, 7/8, 10 and 12 ...
... VERSAPORT™ PLUS V2 RT single-use obturator has a ... , ,The Auto Suture™ VERSAPORT™ PLUS V2 ... 5-12, 11 mm and 12 mm diameters with ... and 5 mm short single-use obturators are not ...
Medicine Products: